Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-25 @ 12:45 AM
NCT ID:
NCT03326167
Eligibility Criteria:
Inclusion Criteria:
* Patients sent to the Nuclear Medicine Department as part of a functional evaluation by dynamic acquisition tomoscintigraphy and who will benefit from coronary angiography in the Louis Pradel Hospital hemodynamics department, depending on the results and the clinical context , outside of an emergency context.
* Patients who received the information and did not object to participate in the study
Exclusion Criteria:
* Patient with a contraindication to pharmacological stress by dipyridamole or regadenoson (acute coronary syndrome, acute pulmonary embolism, hypertension) severe pulmonary artery disease, acute aortic dissection, symptomatic aortic stenosis, hemodynamic instability, acute myocarditis, pericarditis or endocarditis, severe chronic obstructive pulmonary disease, uncompacted type III atrioventricular block, systolic pressure \<90 mmHg, Recent ischemic stroke, hypersensitivity or allergy to active ingredients or excipients)
* Patients under 18 years of age
* Patients with atrial fibrillation complete arrhythmia (ACFA)
* Patients with a history of coronary bypass grafting.
* Patients whose clinical condition requires rapid management not allowing to wait for the completion of the exams
* Pregnancy and breast feeding
* Deprivation of civil rights (guardianship, guardianship, safeguard of justice)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03326167
Study Brief:
Protocol Section:
NCT03326167